Sprint Bioscience
Stockholm
About Sprint Bioscience
Sprint Bioscience AB offers a modular gene-to-lead drug discovery platform for fragment-based drug discovery, including protein expression and purification, fragment screening, X-ray crystallography, and expansion of fragments into a patented lead series. Sprint Bioscience is based in Stockholm, Sweden.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $5.4M
- Last round: Series Unknown (Mar 2016)
- Website: sprintbioscience.com
- Phone: +46 8 411 44 55
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/sprint-bioscience-145359 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.